These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5515480)

  • 1. [Extrapyramidal syndrome in animal experiments: rôle of calcium and o-methylated derivatives].
    Radouco-Thomas S
    Laval Med; 1970 Sep; 41(7):886-93. PubMed ID: 5515480
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental findings and new aspects in extrapyramidal diseases].
    Birkmayer W
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(1):128-39. PubMed ID: 4226878
    [No Abstract]   [Full Text] [Related]  

  • 3. [Motor and psychomotor activity of striatal monoamines].
    Poirier LJ; Bédard P; Larochelle L
    Laval Med; 1970 Sep; 41(7):894-6. PubMed ID: 4994702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemistry of the extrapyramidal system--from anatomical viewpoint].
    Sano Y; Murase Y
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):859-68. PubMed ID: 4898006
    [No Abstract]   [Full Text] [Related]  

  • 5. Dyskinesia in rats following chemical stimulation of the neostriatum.
    Dill RE; Nickey WM; Little MD
    Tex Rep Biol Med; 1968; 26(1):101-6. PubMed ID: 5661801
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A; Bartholini G; Gey KF; Jenni A
    Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison between the effect of L-dopa and its methylated ester on cerebral dopamine and noradrenaline of rats exposed to oxypertin].
    Van den Driessche J; Sado M; Linée P; Lacroix P; Le Clec'h G; Delamaire J; Patay M
    C R Seances Soc Biol Fil; 1973; 167(5):754-9. PubMed ID: 4799139
    [No Abstract]   [Full Text] [Related]  

  • 8. Extrapyramidal dopamine regulation by cholecystokinin and its role in Parkinson's disease.
    Diamond BI; Pasinetti G; Hitri A; Borison RL
    Adv Neurol; 1984; 40():483-8. PubMed ID: 6695625
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonergic-dopaminergic interactions and extrapyramidal function.
    Chase TN
    Adv Biochem Psychopharmacol; 1974; 11(0):377-85. PubMed ID: 4367649
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs and motor functions.
    Gordon N
    Dev Med Child Neurol; 1971 Jun; 13(3):384-6. PubMed ID: 4398415
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical and pharmacological aspects of Parkinsonism.
    Carlsson A
    Acta Neurol Scand Suppl; 1972; 51():11-42. PubMed ID: 4351191
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine and extrapyramidal motor function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
    [No Abstract]   [Full Text] [Related]  

  • 14. [Submicroscopic catecholamine stores as sites of attack of the psychopharmaca, reserpine and monoamine oxidase inhibitors].
    Hassler R; Bak IJ
    Nervenarzt; 1966 Nov; 37(11):493-8. PubMed ID: 5983176
    [No Abstract]   [Full Text] [Related]  

  • 15. Homovanillic acid in the ventricular fluid of patients with Parkinson's disease and other extrapyramidal diseases.
    Papeschi R; Molina-Negro P; Sourkes TL; Hardy J; Bertrand C
    Laval Med; 1970 Sep; 41(7):899-901. PubMed ID: 5509486
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Logemann G
    Arzneimittelforschung; 1970 Jul; 20(7):894-6. PubMed ID: 5536051
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biochemical aspects of involuntary movements (author's transl)].
    Nakamura S; Kameyama M
    No To Shinkei; 1981 Dec; 33(12):1177-85. PubMed ID: 7034752
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome].
    Tissot R
    Presse Med (1893); 1969 Apr; 77(17):617-8. PubMed ID: 5785080
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of thioproperazine on dopamine and noradrenaline metabolism in chronic schizophrenia].
    Panisset VC; Albert JM; Rocheleau LP; Dhaiti G; Tétreault L
    Laval Med; 1970 Sep; 41(7):917-22. PubMed ID: 4396422
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of brain dopamine].
    Rybakowski J
    Psychiatr Pol; 1972; 6(3):341-4. PubMed ID: 4560234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.